Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 10/2001

01-10-2001 | Article

Early-onset Type II diabetes mellitus in Italian families due to mutations in the genes encoding hepatic nuclear factor 1α and glucokinase

Authors: C. Gragnoli, B. N. Cockburn, F. Chiaramonte, A. Gorini, G. Marietti, G. Marozzi, A. M. Signorini

Published in: Diabetologia | Issue 10/2001

Login to get access
Metadata
Title
Early-onset Type II diabetes mellitus in Italian families due to mutations in the genes encoding hepatic nuclear factor 1α and glucokinase
Authors
C. Gragnoli
B. N. Cockburn
F. Chiaramonte
A. Gorini
G. Marietti
G. Marozzi
A. M. Signorini
Publication date
01-10-2001
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/2001
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s001250100644

Other articles of this Issue 10/2001

Diabetologia 10/2001 Go to the issue

For debate

Does partial preservation of residual beta-cell function justify immune intervention in recent onset Type I diabetes?

ARTICLE

New aspects of the insulin resistance syndrome: impact on haematological parameters

Article

Quantification of beta-cell function during IVGTT in Type II and non-diabetic subjects: assessment of insulin secretion by mathematical methods

Article

A missense mutation in the human melanocortin-4 receptor gene in relation to abdominal obesity and salivary cortisol

Article

The content of glycogen phosphorylase and glycogen in preparations of sarcoplasmic reticulum–glycogenolytic complex is enhanced in diabetic rat skeletal muscle

Articles

The relation of glycaemia to the risk of development and progression of retinopathy in the Diabetic Control and Complications Trial
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits